These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 20550510)

  • 1. Systematic generation of chemical structures for rational drug design based on QSAR models.
    Funatsu K; Miyao T; Arakawa M
    Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screening and rational drug design method using structure generation system based on 3D-QSAR and docking.
    Chen HF; Dong XC; Zen BS; Gao K; Yuan SG; Panaye A; Doucet JP; Fan BT
    SAR QSAR Environ Res; 2003 Aug; 14(4):251-64. PubMed ID: 14506869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds.
    Marrero-Ponce Y; Casañola-Martín GM; Khan MT; Torrens F; Rescigno A; Abad C
    Curr Pharm Des; 2010; 16(24):2601-24. PubMed ID: 20642427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Methodologies in the Exploration of Marine Natural Product Leads.
    Pereira F; Aires-de-Sousa J
    Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30011882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR studies in the discovery of novel type-II diabetic therapies.
    Abuhammad A; Taha MO
    Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.
    Hasan MR; Alsaiari AA; Fakhurji BZ; Molla MHR; Asseri AH; Sumon MAA; Park MN; Ahammad F; Kim B
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual darwinian drug design: QSAR inverse problem, virtual combinatorial chemistry, and computational screening.
    de Julian-Ortiz JV
    Comb Chem High Throughput Screen; 2001 May; 4(3):295-310. PubMed ID: 11375744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collection and preparation of molecular databases for virtual screening.
    Saxena AK; Prathipati P
    SAR QSAR Environ Res; 2006 Aug; 17(4):371-92. PubMed ID: 16920660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-Based Ligand Designing.
    Katiyar SP; Malik V; Kumari A; Singh K; Sundar D
    Methods Mol Biol; 2018; 1762():123-144. PubMed ID: 29594771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
    Abdolmaleki A; Ghasemi JB; Ghasemi F
    Curr Drug Targets; 2017; 18(5):556-575. PubMed ID: 26721410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.
    Speck-Planche A; Cordeiro MN
    Expert Opin Drug Discov; 2015 Mar; 10(3):245-56. PubMed ID: 25613725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
    Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
    Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.
    Vucicevic J; Nikolic K; Mitchell JBO
    Curr Med Chem; 2019; 26(21):3874-3889. PubMed ID: 28707592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.